Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 9, Issue 1, Pages 39-44Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.7b00417
Keywords
AMPK; activator; T2DM; ACC; liver-selectivity
Categories
Ask authors/readers for more resources
5'-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and weight loss including lipid and glucose trafficking. As such, the enzyme has long been of interest as a target for the treatment of Type 2 Diabetes Mellitus. We describe the optimization of beta 1-selective, liver-targeted AMPK activators and their evolution into systemic pan-activators capable of acutely lowering glucose in mouse models. Identifying surrogates for the key acid moiety in early generation compounds proved essential in improving beta 2-activation and in balancing improvements in plasma unbound fraction while avoiding liver sequestration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available